Alexander Farivar
Alexander S Farivar, MD

Alexander S Farivar, MD

Alexander S Farivar, MD
Specialty

Esophageal Surgery, Robotic Surgery, Thoracic Surgery

Clinical Interests / Special Procedures Performed

Bloodless Surgery, Chest Wall Resections, Chest Wall Tumors, da Vinci (Robot-Assisted Surgery), Esophageal Achalasia, Esophageal Cancer, Esophagectomies, Esophogastroduodenoscopy (EGD), Gastro-Esophageal Junction, Gastro-Esophageal Reflux, GI Stents, Laparoscopic Surgery, LINX System, Lung Cancer, Lungs & Esophagus, Mediastinal Masses, Mesothelioma, Minimally Invasive Procedures, Minimally Invasive Surgery, Myasthenia Gravis, Obesity, Palliative Care, Pectus excavatum repair for adults, Pectus excavatum repair for pediatrics, Peg Tube Insertion, Pleural Diseases, Pulmonary Disease, Pulmonary Pathology, Sarcoma, Soft Tissue Sarcomas, Swedish Cancer Institute, Thoracic Surgery, Thoracic Surgery (robotic), Thoracoscopic Lobectomies, Thorascopic Surgery, Thymoma, Tracheal Problems, Tracheal Resections, Tuberculosis

  • Accepting Children: Yes
  • Accepting New Patients: Yes
  • Accepting Medicare: Yes
  • Accepting Medicaid/DSHS: Yes
Payment Methods Accepted:

Medicare, Medicaid/DSHS, Bill Insurance, VISA, Master Card, Cash, Check, Payment Plan, American Express, Billing Service, Discover Card, Money Order, Pending, Purchase Order, Sliding Fee Scale

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

Appointments

Surgical Director of Pleural Diseases - Swedish Cancer Institute and Center for Pleural Diseases

Clinical Instructor, General Surgery Residency Program - Swedish Medical Center

 


 

 

 

Professional Highlights

Dr. Farivar was voted "Top Doctors" in Seattle Metropolitan Magazine (2011, 2012)

Nearly 4,500 physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones. 

News Release

Dr. Farivar was voted "Top Doctors" in Asbestos.com.
 

Because mesothelioma is so rare, representing about 0.3 percent of all diagnosed cancers annually, and has no known cure, people who have the disease are urged to find a specialist to treat it.

Dr. Farivar was voted "Top Doctors" in Seattle Magazine (2013)

Surveys were mailed to physicians in King, Pierce, Snohomish and Kitsap counties. The survey asked physicians to name the provider they would seek out or recommend to loved ones.

News Release


Videos

What are the surgical options for early stage lung cancer?

What is a lobectomy to treat lung cancer?

Does the robot do the surgery (robotic lobectomy)

Advantages of robotic surgery

Why choose Swedish (robotic surgery)?

Who is a good candidate (robotic surgery)?

Mesothelioma and malignant pleural issues

Philosophy of Care

To offer compassionate and individualized care for every patient

Personal Interests

waterskiing, wakeboarding, reading, hiking

Medical School

Boston University Medical School

Residency

University of Washington General Surgery Residency

Fellowship(s)

Brigham and Women's - Harvard Medical School

Board Certifications

American Board of Surgery, American Board of Thoracic Surgery

Professional Associations:

STS, ACCP

Additional Information:

Appointments

Surgical Director of Pleural Diseases - Swedish Cancer Institute and Center for Pleural Diseases

Clinical Instructor, General Surgery Residency Program - Swedish Medical Center

 


 

 

 

Professional Highlights

Dr. Farivar was voted "Top Doctors" in Seattle Metropolitan Magazine (2011, 2012)

Nearly 4,500 physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones. 

News Release

Dr. Farivar was voted "Top Doctors" in Asbestos.com.
 

Because mesothelioma is so rare, representing about 0.3 percent of all diagnosed cancers annually, and has no known cure, people who have the disease are urged to find a specialist to treat it.

Dr. Farivar was voted "Top Doctors" in Seattle Magazine (2013)

Surveys were mailed to physicians in King, Pierce, Snohomish and Kitsap counties. The survey asked physicians to name the provider they would seek out or recommend to loved ones.

News Release


Videos

What are the surgical options for early stage lung cancer?

What is a lobectomy to treat lung cancer?

Does the robot do the surgery (robotic lobectomy)

Advantages of robotic surgery

Why choose Swedish (robotic surgery)?

Who is a good candidate (robotic surgery)?

Mesothelioma and malignant pleural issues

PUBLICATIONS & PRESENTATIONS

Publications:

Farivar AS, Cerfolio RJ, Vallières E, Knight AW, Bryant A, Lingala V, Aye RW, Louie BE. Comparing robotic lung resection with thoracotomy and video-assisted thoracoscopic surgery cases entered into the society of thoracic surgeons database. Innovations (Phila). 2014 Jan-Feb;9(1):10-5. 
 
Deen SA, Wilson JL, Wilshire CL, Vallières E, Farivar AS, Aye RW, Ely RE, Louie BE. Defining the Cost of Care for Lobectomy and Segmentectomy: A Comparison of Open, Video-Assisted Thoracoscopic, and Robotic Approaches. Ann Thorac Surg. 2014 Mar;97(3):1000-7. 
 
Deen S, Farivar AS, Louie BE. Thoracic techniques: robotic thymectomy for thymoma. Indian J Surg Oncol. 2013 Jun;4(2):132-7.
 
Wilson JL, Louie BE, Farivar AS, Vallières E, Aye RW. Fully covered self-expanding metal stents are effective for benign esophagogastric disruptions and strictures. J Gastrointest Surg. 2013 Dec;17(12):2045-50.
 
Hunt BM, Louie BE, Dunst CM, Lipham JC, Farivar AS, Sharata A, Aye RW. Esophagectomy for failed endoscopic therapy in patients with high-grade dysplasia or intramucosal carcinoma. Dis Esophagus. 2013 Jun 24. 
 
Hunt BM, Louie BE, Schembre DB, Bohorfoush AG, Farivar AS, Aye RW. Outcomes in patients who have failed endoscopic therapy for dysplastic Barrett's metaplasia or early esophageal cancer. Ann Thorac Surg. 2013 May;95(5):1734-40. 
 
Qureshi AP, Aye RW, Buduhan G, Knight A, Orlina J, Farivar AS, Wagner OJ, McHugh S, Louie BE. The laparoscopic Nissen-Hill hybrid: pilot study of a combined antireflux procedure. Surg Endosc. 2013 Jun;27(6):1945-52.
 
Louie BE, Kapur S, Blitz M, Farivar AS, Vallières E, Aye RW.  Length and pressure of the reconstructed lower esophageal sphincter is determined by both crural closure and Nissen fundoplication. J Gastrointest Surg. 2013 Feb;17(2):236-43.
 
Wagner OJ, Louie BE, Vallières E, Aye RW, Farivar AS. Near-infrared fluorescence imaging can help identify the contralateral phrenic nerve during robotic thymectomy. Ann Thorac Surg. 2012 Aug;94(2):622-5.
 
Egan M, Louie BE, Farivar AS, Wagner O, Vallières E. Laparoscopic repair of gastric herniation after extrapleural pneumonectomy for mesothelioma. Ann Thorac Surg. 2012 May;93(5)
 
Hunt BM, Farivar AS, Vallières E, Louie BE, Aye RW, Flores EE, Gorden JA. Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions. Ann Thorac Surg. 2012 Oct;94(4):1053-7
 
Louie BE, Farivar AS, Aye RW, Vallières E. Early experience with robotic lung resection results in similar operative outcomes and morbidity when compared with matched video-assisted thoracoscopic surgery cases. Ann Thorac Surg. 2012 May;93(5):1598-604
 
Farivar AS, Louie BE, Aye RW, Horton MP, Vallières E. Extrapleural pneumonectomy for primary pleural mullerian tumor in a young woman. Ann Thorac Surg. 2012 Jan;93(1)
 
Louie BE, Kapur S, Farivar AS, Youssef SJ, Gorden J, Aye RW, Vallières E. Safety and utility of mediastinoscopy in non-small cell lung cancer in a complex mediastinum. Ann Thorac Surg. 2011 Jul;92(1):278-82
 
Louie BE, Blitz M, Farivar AS, Orlina J, Aye RW. Repair of symptomatic giant paraesophageal hernias in elderly (>70 years) patients results in improved quality of life. J Gastrointest Surg. 2011 Mar;15(3):389-96
 
McCourtie AS, Merry HE, Wolf PS, FitzSullivan E, Keech JC, Farivar AS, Mulligan MS. Synergistic protection in lung ischemia-reperfusion injury with calcineurin and thrombin inhibition. Ann Thorac Surg. 2010 Jun;89(6):1766-71.
 
Youssef SJ, Louie BE, Farivar AS, Blitz M, Aye RW, Vallières E. Comparison of open and minimally invasive thymectomies at a single institution. Am J Surg. 2010 May;199(5):589-93. 
 
Nash RA, Yunosov M, Abrams K, Hwang B, Castilla-Llorente C, Chen P, Farivar AS, Georges GE, Hackman RC, Lamm WJ, Lesnikova M, Ochs HD, Randolph-Habecker J, Ziegler SF, Storb R, Storer B, Madtes DK, Glenny R, Mulligan MS. Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation. Am J Transplant. 2009 May;9(5):1037-47.
 
 
McCourtie AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Mackinnon-Patterson B, Keech JC, Fitzsullivan E, Mulligan MS.  Alveolar macrophage secretory products effect type 2 pneumocytes undergoing hypoxia-reoxygenation. Ann Thorac Surg. 2008 Dec;86(6):1774-9.
 
Wolf PS, Merry HE, Farivar AS, McCourtie AS, Mulligan MS. Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury. J Thorac Cardiovasc Surg. 2008 Mar;135(3):656-65. 
 
McCourtie AS, Merry HE, Farivar AS, Goss CH, Mulligan MS. Alveolar macrophage secretory products augment the response of rat pulmonary artery endothelial cells to hypoxia and reoxygenation. Ann Thorac Surg. 2008 Mar;85(3):1056-60.
 
McCourtie AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Szabo C, Mulligan MS. Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation. Exp Mol Pathol. 2008 Apr;84(2):141-4. 
 
Farivar AS, Merry HE, Fica-Delgado MJ, McCourtie AS, Mackinnon-Patterson BC, Mulligan MS. Interleukin-6 regulation of direct lung ischemia reperfusion injury. Ann Thorac Surg. 2006 Aug;82(2):472-8.
 
Farivar AS, Yunusov MY, Chen P, Leone RJ, Madtes DK, Kuhr CS, Spector MR,  Abrams K, Hwang B, Nash RA, Mulligan MS. Optimizing a canine survival model of orthotopic lung transplantation. Transplant Proc. 2006 Jun;38(5):1638-40.
 
Farivar AS, Delgado MF, McCourtie AS, Barnes AD, Verrier ED, Mulligan MS. Crosstalk between thrombosis and inflammation in lung reperfusion injury. Ann Thorac Surg. 2006 Mar;81(3):1061-7.
 
Chen P, Farivar AS, Mulligan MS, Madtes DK. Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation. Am J Respir Cell Mol Biol. 2006 Apr;34(4):464-72
 
Farivar AS, MacKinnon-Patterson B, Barnes AD, Mulligan MS.  The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury. J Heart Lung Transplant. 2005 Dec;24(12):2235-42.
 
Farivar AS, McCourtie AS, MacKinnon-Patterson BC, Woolley SM, Barnes AD, Chen M, Jagtap P, Szabó C, Salerno CT, Mulligan MS. Poly (ADP) ribose polymerase inhibition improves rat cardiac allograft survival. Ann Thorac Surg. 2005 Sep;80(3):950-6.
 
Farivar AS, Mackinnon-Patterson B, McCourtie AS, Namkung J, Ward PA, Mulligan MS. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha. Exp Mol Pathol. 2005 Jun;78(3):190-7.
 
Farivar AS, Mackinnon-Patterson BC, McCourtie AS, Ward PA, Mulligan MS. The role of CC and CXC chemokines in cardiac allograft rejection in rats. Exp Mol Pathol. 2005 Jun;78(3):171-6.
 
Farivar AS, Mackinnon-Patterson BC, Barnes AD, McCourtie AS, Mulligan MS. Cyclosporine modulates the response to hypoxia-reoxygenation in pulmonary artery endothelial cells. Ann Thorac Surg. 2005 Mar;79(3):1010-6.
 
Woolley SM, Farivar AS, Naidu BV, Salzman A, Szabo C, Thomas R, Fraga C, Mulligan  MS. Role of poly (ADP) ribose synthetase in lung ischemia-reperfusion injury. J Heart Lung Transplant. 2004 Nov;23(11):1290-6.
 
Farivar AS, Woolley SM, Naidu BV, Fraga CH, Byrne K, Thomas R, Salzman AL, Szabo CS, Mulligan MS. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts. J Heart Lung Transplant. 2004 Aug;23(8):993-1002.
 
Farivar AS, Mackinnon-Patterson B, Woolley S, Namkung J, Shimamoto A, Verrier ED, Mulligan MS. FR167653 reduces obliterative airway disease in rats. J Heart Lung Transplant. 2004 Aug;23(8):985-92.
 
Farivar AS, Vallières E, Kowdley KV, Wood DE, Mulligan MS. Airway obstruction complicating esophageal stent placement in two post-pneumonectomy patients. Ann Thorac Surg. 2004 Aug;78(2):e22-3.
 
Farivar AS, Woolley SM, Fraga CH, Thomas R, Salzman AL, Szabo C, Mulligan MS. Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury. Ann Thorac Surg. 2004 Jun;77(6):1938-43.
 
Farivar AS, Krishnadasan B, Naidu BV, Woolley SM, Verrier ED, Mulligan MS. Alpha chemokines regulate direct lung ischemia-reperfusion injury. J Heart Lung Transplant. 2004 May;23(5):585-91.
 
Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH, Goss CH, Mulligan MS. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2004 May;127(5):1502-8.
 
Krishnadasan B, Farivar AS, Naidu BV, Woolley SM, Byrne K, Fraga CH, Mulligan MS. Beta-chemokine function in experimental lung ischemia-reperfusion injury. Ann Thorac Surg. 2004 Mar;77(3):1056-62.
 
Farivar AS, Woolley SM, Fraga CH, Byrne K, Mulligan MS. Proinflammatory response of alveolar type II pneumocytes to in vitro hypoxia and reoxygenation. Am J Transplant. 2004 Mar;4(3):346-51.
 
Woolley SM, Farivar AS, Naidu BV, Rosengart M, Thomas R, Fraga C, Mulligan MS. Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg. 2004 Feb;127(2):376-84.
 
Naidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED, Mulligan MS. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant. 2004 Jan;23(1):128-34.
 
Farivar AS, Krishnadasan B, Naidu BV, Woolley SM, Mulligan MS. The role of the beta chemokines in experimental obliterative bronchiolitis. Exp Mol Pathol. 2003 Dec;75(3):210-6.
 
Naidu BV, Farivar AS, Woolley SM, Byrne K, Mulligan MS. Chemokine response of pulmonary artery endothelial cells to hypoxia and reoxygenation. J Surg Res. 2003 Oct;114(2):163-71.
 
Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga C, Mulligan MS. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg. 2003 Aug;126(2):482-9.
 
 Naidu BV, Krishnadasan B, Farivar AS, Woolley SM, Thomas R, Van Rooijen N, Verrier ED, Mulligan MS. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2003 Jul;126(1):200-7.
 
Farivar AS, Krishnadasan B, Naidu BV, Woolley SM, Verrier ED, Mulligan MS. Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury. Ann Thorac Surg. 2003 Jul;76(1):253-9.
 
Naidu BV, Farivar AS, Woolley SM, Fraga C, Salzman AL, Szabo C, Groves JT, Mulligan MS. Exp Mol Pathol. 2003 Aug;75(1):12-7.
 
Naidu BV, Farivar AS, Krishnadasan B, Woolley SM, Grainger DJ, Verrier ED, Mulligan MS. Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis. Ann Thorac Surg. 2003 Apr;75(4):1118-22.

Book Chapters:
Farivar AS, Lukanich J. "Resection of substernal goiter". In Sugarbaker DJ, Bueno R, Krasna M, Mentzer SJ, Zellos L (editors), Adult Chest Surgery. McGraw Hill, Chapter 133: 1108-15, 2009

Reviews: Malignant Pleural Mesothelioma. Where do we stand in 2011? Respiratory Journal. 2011. Bharadwaj and Farivar.

Presentations:

Farivar, Gorden and Hunt. A comparison of VATS talc vs pleural catheter for management of malignant pleural effusion. Southern Thoracic Surgical Association, 2011.

Farivar AS, McCourtie AS, Delgado MF, MacKinnon-Patterson B, Mulligan MS. "Crosstalk between Thrombosis and Inflammation: Thrombin Activation after Lung Reperfusion". Bayer Research Scientific Committee. Phoenix, AZ. May 20, 2005.

Mulligan MS, Farivar AS, Yunusov M, Kuhr C, Leone R, Chen P, Madtes D, Glenny R, Storb R, Nash R. "Chimerism and tolerance induction to allogeneic canine lung grafts". American Transplant Congress. May 2005.

Farivar AS, MacKinnon-Patterson B, Woolley SM, Mulligan MS. "The Anti-inflammatory Properties of Mycophenelate Mofetil in Acute Oxidative Lung Injury". International Society for Heart and Lung Transplantation. Philadelphia, PA. April, 2005.

Farivar AS, MacKinnon-Patterson B, Woolley SM, Mulligan MS. "The Role of Poly (ADP) Ribose Synthetase in Acute Cellular Rejection in Cardiac Transplantation in Rats". Plenary Session of American Society of Transplant Surgery. January, 2005.

McCourtie A, Farivar AS, Delgado M, Mulligan MS. "Patterns of expression of STAT and SOCS proteins after lung ischemia and reperfusion". American Society of Transplant Surgery. January, 2005.

Farivar AS, MacKinnon-Patterson B, Woolley SM, Fraga C, Thomas R, Mulligan MS. "The Role of p38 in Experimental Obliterative Airway Disease in Rats". The International Society of Heart and Lung Transplantation. San Francisco, CA. April 2004.

Farivar AS, Woolley SM, Fraga CH, Salzman AS, Szabo C, Mulligan MS. "Intratracheal Poly (ADP) Ribose Synthetase Ameliorates Experimental Lung Ischemia Reperfusion Injury". The Society of Thoracic Surgeons. San Antonio, TX. January, 2004.

Farivar AS, MacKinnon-Patterson B, Woolley SM, Mulligan MS. "Obliterative Airway Disease in Tracheal Allografts Requires Tumor Necrosis Factor Alpha". American College of Surgery. New Orleans. 2004.

Farivar AS, MacKinnon-Patterson B, Woolley SM, Mulligan MS. "Alveolar macrophage secretory products synergistically amplify alveolar epithelial response to oxidative stress". The Annual Meeting CHEST. Seattle, WA. 2004.

Farivar AS, Naidu BV, Woolley SM, Salzman AS, Mulligan MS. "Inhibition of Poly (ADP) Ribose Synthetase Ameliorates Experimental Obliterative Bronchiolitis in Rat Tracheal Allografts". The International Society of Heart and Lung Transplantation Meeting. Vienna, Austria. 2003.

 

Mesothelioma update: shorter course of treatment and improved survival rates?

There have been some very exciting recent developments we (the Thoracic Surgery team at Swedish Cancer Institute) are utilizing in the treatment of malignant pleural mesothelioma (MPM).

Over the past year we have offered some of our patients deemed appropriate for surgery a more streamlined approach to their overall care. Previously we have tried to offer chemotherapy, surgery, and radiation to all patients who were healthy and strong enough to undergo the three treatments, as mesothelioma is an aggressive cancer requiring aggressive treatment to optimize survival. This new approach still offers both surgery and radiation, but chemotherapy is given only to those found to have cancer in lymph nodes in the center of chest during surgery.

The advantages of this new treatment paradigm are ...

Pectus excavatum – it looks like the chest is sinking inward

Have you ever noticed someone whose chest sinks inward in the front, kind of like a funnel? The first time I ever noticed this bony malformation was when I was in high school, and a friend of mine on the soccer team had one. It was called “pectus excavatum,” he told me.

In my thoracic surgery training, I was often called upon to evaluate patients with this chest wall abnormality. As a result, I began to delve deeper into some of the issues that may affect people with this type of defect.

Pectus excavatum is the most common chest wall deformity and results from abnormal development of the sternum and its attachments. Most patients are self conscious about the defect and usually focus on its appearance but because this is usually present for much of a person’s life, symptoms associated with it may not be totally obvious. Individuals affected generally get used to how they feel and try to overcome any limitations to the best of their abilities without even knowing that’s what they are doing. Most patients describe some chest discomfort, shortness of breath when exerting themselves, lack of endurance, or feeling embarrassed in social situations when their shirt is off. It is not uncommon to hear patients say that they have trouble keeping up with their friends during activities, or that they avoid any activities that would require them to take off their shirt in public-such as going to a pool.

Most physicians aren’t even aware that there is an effective treatment for pectus excavatum...

Helping patients with mesothelioma

One of my passions is helping patients with malignant pleural mesothelioma (MPM). This is an aggressive cancer that is asbestos related, and affects the abdomen and/or chest. I specialize in chest mesothelioma. One of the reasons I trained in thoracic surgery, and mesothelioma surgery in specific, is that I believe passionately that there are treatment options for every single patient that can improve their quality of life, if not to give them a chance of cure and long term survival.

This optimism unfortunately is not a common belief among physicians. My experience in training in mesothelioma surgery at Brigham and Women’s Hospital in Boston, arguably the biggest international center treating mesothelioma, has shown me that people can survive for years after aggressive treatment including surgery. I know we can help patients with mesothelioma feel and breathe better, and enjoy their remaining years.

I’d like to present two of my patients to highlight this optimism.

Results 1-3 of 3
  • 1

Offices

Swedish Thoracic Surgery / First Hill
1101 Madison Street
Suite 900
Seattle, WA 98104
Phone: 206-215-6800
Fax: 206-215-6801
Map & Directions

Physicians: Is this your profile? Click here for info